AI Bias Analysis
4 models · Takes ~15 seconds
(MedPage Today) -- CHICAGO -- A second-line triplet regimen involving the novel intravenous drug gedatolisib significantly reduced the risk of progression or death in PIK3CA-mutant hormone receptor (HR)-positive breast cancer, a phase III study...
Source
MedPage Today
Opens original article in a new tab
The Supreme Court unanimously ruled that Hikma Pharmaceutical did not infringe patents held by Amarin in a decision with implications for lawsuits over so-called skinny labels.
(MedPage Today) -- The following contains links to social media websites including Bluesky, X, TikTok, Instagram, Facebook, and LinkedIn. Allergist Zachary Rubin, MD, explained the "why" behind the standing ovation received by a game-changing...
(MedPage Today) -- The FDA approved intravenous cefepime and zidebactam (Zaynich) for complicated urinary tract infections (UTIs), including pyelonephritis, caused by susceptible gram-negative bacteria in adults, Wockhardt announced. The novel...
For pancreatic cancer patients, the surge in interest for an exciting new drug is leaving them fearful about when they might get the treatment or if there will be enough…
